|Tested species reactivity||Human|
|Published species reactivity||Human, Not Applicable|
|Host / Isotype||Mouse / IgG1|
|Immunogen||Glycoproteins purified from human NALM-1 cell line.|
|Storage buffer||PBS with 0.2% BSA|
|Contains||15mM sodium azide|
|Storage Conditions||4° C, store in dark, DO NOT FREEZE!|
|Tested Applications||Dilution *|
|Flow Cytometry (Flow)||20 ul/10^6 cells|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
This gene encodes a sialoglycoprotein that is expressed on mature granulocytes and in many B cells. The encoded protein is anchored via a glycosyl phosphatidylinositol (GPI) link to the cell surface. [provided by RefSeq, Jul 2008]
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
|Not Applicable||Not Cited||
Tunicamycin-induced endoplasmic reticulum stress reduces in vitro subpopulation and invasion of CD44+/CD24- phenotype breast cancer stem cells.
MA1-10154 was used in flow cytometry to learn about the reduction of an in vitro subpopulation and invasion of CD44+/CD24- phenotype breast cancer stem cells after tunicamycin-induced endoplasmic reticulum stress
|Nami B,Donmez H,Kocak N||Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie (68:419)||2016|
|Not Applicable||Not Cited||
Profiling of normal and malignant breast tissue show CD44high/CD24low phenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers.
MA1-10154 was used in flow cytometry to determine the phenotype and function of stem/progenitor cells in normal mammary epithelial cell populations and their malignant counterparts
|Ghebeh H,Sleiman GM,Manogaran PS,Al-Mazrou A,Barhoush E,Al-Mohanna FH,Tulbah A,Al-Faqeeh K,Adra CN||BMC cancer (13:null)||2013|
|Not Applicable||Not Cited||
A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus.
MA1-10154 was used in flow cytometry to discuss the frequency and contribution of CD27- memory B cells to systemic lupus erythematosus
|Wei C,Anolik J,Cappione A,Zheng B,Pugh-Bernard A,Brooks J,Lee EH,Milner EC,Sanz I||Journal of immunology (Baltimore, Md. : 1950) (178:6624)||2007|
CD24 and CD44 in salivary gland pleomorphic adenoma and in human salivary gland morphogenesis: differential markers of glandular structure or stem cell indicators?
MA1-10154 was used in immunohistochemistry to study whether CD24 and CD44 expression in salivary glands can be used as markers of cancer stem cells
|Ianez RC,Coutinho-Camillo CM,Buim ME,Pinto CA,Soares FA,Lourenço SV||Histopathology (62:1075)||2013|
Acetaminophen-induced differentiation of human breast cancer stem cells and inhibition of tumor xenograft growth in mice.
MA1-10154 was used in immunohistochemistry to screen compounds able to induce differentiation of cancer stem cells
|Takehara M,Hoshino T,Namba T,Yamakawa N,Mizushima T||Biochemical pharmacology (81:1124)||2011|
CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.
MA1-10154 was used in immunohistochemistry to study the role of CD24 in tumor invasion and its prognostic significance in hepatocellular carcinoma
|Yang XR,Xu Y,Yu B,Zhou J,Li JC,Qiu SJ,Shi YH,Wang XY,Dai Z,Shi GM,Wu B,Wu LM,Yang GH,Zhang BH,Qin WX,Fan J||Clinical cancer research : an official journal of the American Association for Cancer Research (15:5518)||2009|
Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.
MA1-10154 was used in immunohistochemistry to study whether cancer stem cells are clinically significant for resistance to chemotherapy in human breast cancers
|Tanei T,Morimoto K,Shimazu K,Kim SJ,Tanji Y,Taguchi T,Tamaki Y,Noguchi S||Clinical cancer research : an official journal of the American Association for Cancer Research (15:4234)||2009|
Laser capture microdissection-microarray analysis of focal segmental glomerulosclerosis glomeruli.
MA1-10154 was used in immunohistochemistry to analyse the focal segmental glomerulosclerosis glomeruli by laser capture microdissection-microarray method
|Bennett MR,Czech KA,Arend LJ,Witte DP,Devarajan P,Potter SS||Nephron. Experimental nephrology (107:e30)||2007|
CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma.
MA1-10154 was used in immunohistochemistry to study CD24 expression as a prognostic factor in intrahepatic cholangiocarcinoma
|Su MC,Hsu C,Kao HL,Jeng YM||Cancer letters (235:34)||2006|
Cytoplasmic CD24 expression in colorectal cancer independently correlates with shortened patient survival.
MA1-10154 was used in immunohistochemistry to study the prognostic value of cytoplasmic CD24 expression in colorectal cancer
|Weichert W,Denkert C,Burkhardt M,Gansukh T,Bellach J,Altevogt P,Dietel M,Kristiansen G||Clinical cancer research : an official journal of the American Association for Cancer Research (11:6574)||2005|
Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival.
MA1-10154 was used in immunohistochemistry to profile the expression patterns of microdissected prostate cancer samples to identify new prognostic markers
|Kristiansen G,Pilarsky C,Wissmann C,Kaiser S,Bruemmendorf T,Roepcke S,Dahl E,Hinzmann B,Specht T,Pervan J,Stephan C,Loening S,Dietel M,Rosenthal A||The Journal of pathology (205:359)||2005|
CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer.
MA1-10154 was used in immunohistochemistry to study the prognostic value of CD24 expression in low grade or organ confined prostate cancer
|Kristiansen G,Pilarsky C,Pervan J,Stürzebecher B,Stephan C,Jung K,Loening S,Rosenthal A,Dietel M||The Prostate (58:183)||2004|
CD24 expression as a marker for predicting clinical outcome in human gliomas.
MA1-10154 was used in western blot to study the prognostic value of CD24 expression in human gliomas
|Deng J,Gao G,Wang L,Wang T,Yu J,Zhao Z||Journal of biomedicine and biotechnology (2012:null)||2012|
CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma.
MA1-10154 was used in western blot to study the prognostic value of CD24 overexpression in esophageal squamous cell carcinoma
|Sano A,Kato H,Sakurai S,Sakai M,Tanaka N,Inose T,Saito K,Sohda M,Nakajima M,Nakajima T,Kuwano H||Annals of surgical oncology (16:506)||2009|
The role of extracellular factors in human metastatic chordoma cell growth in vitro.
MA1-10154 was used in western blot to study the role of the extracellular microenvironment in human metastatic chordoma cell growth in vitro
|Ostroumov E,Hunter CJ||Spine (32:2957)||2007|